Monitoring Agency Report for the quarter ended June 30, 2026

August 14, 2026 BSE Limited National Stock Exchange of India Corporate Relationship Department Ltd. P.J. Towers, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (East) Mumbai - 400 051 Scrip Code: 506109 Symbol: GENESYS Dear Sir/Madam, Subject: Monitoring Agency Report for the quarter ended June 30, 2026 Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 173A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, enclosed herewith is the Monitoring Agency Report for the quarter ended June 30, 2026 issued by CARE Ratings Limited, Monitoring Agency for the utilisation of the proceeds raised through Qualified Institutions Placement. The aforesaid information is also being made available on the website of the Company at www.igenesys.com Kindly take the above information on your record. Thanking you, Yours faithfully, For Genesys International Corporation Limited Kushal Jain Company Secretary & Compliance Officer Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 Monitoring Agency Report No. CARE/HO/GEN/2026-2027/1157 The Board of Directors Genesys International Corporation Limited 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai, Maharashtra-400 096 August 14, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Qualified Institutional Placement (QIP) of equity shares of Genesys International Corporation Limited (“the Company”) We write in our capacity of Monitoring Agency for the qualified institutional placement (QIP) of equity shares for the amount aggregating to Rs. 110.00 crore of the Company and refer to our duties cast under Regulation 173A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated March 12, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Raunak Modi Assistant Director raunak.modi@careedge.in Report of the Monitoring Agency Name of the issuer: Genesys International Corporation Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Yes During Q1 FY27, the company transferred issue proceeds of Rs. 17.38 crore from the MA account to the current account from where it was further utilized for purposes other than those specified in offer document. The current account has multiple other debits and credits resulting in comingling of funds. MA notes that company has transferred the abovementioned Rs. 17.38 crore back to the MA account from the current account before the end of the quarter (on June 29 and 30, 2026), which are parked as unutilized issue proceeds on June 30, 2026. However, same is contrary to the ‘interim use of net proceeds’ as defined in offer document. (b) Range of Deviation: 10-25% (Rs. 17.38 crore as compared to issue size) Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The Monitoring Agency (MA) does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Raunak Modi Designation of Authorized person/Signing Authority: Assistant Director 1) Issuer Details: Name of the issuer : Genesys International Corporation Limited Name of the promoter : Sajid Siraj Malik, Late Saroja Siraj Malik, Shazia Ilmi Malik, Sohel Malik, Kilam Holdings Limited, Kadam Holdings Limited Industry/sector to which it belongs : IT Enabled services 2) Issue Details Issue Period : May 14, 2025, to May 16, 2025 Type of issue (public/rights) : Qualified Institutional Placement (QIP) Type of specified securities : Equity Shares IPO Grading, if any : Not applicable Issue size (in crore) : 110.00 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Particulars Reply considered by Monitoring Agency for Comments of the Monitoring Agency Board of Directors preparation of report During Q1 FY27, the company transferred issue proceeds of Rs. No comments 17.38 crore from the MA account to the current account from where it was further utilized for purposes other than those specified in offer document. The current account has multiple other debits and credits resulting in comingling of funds. MA notes that company has transferred the abovementioned Rs. 17.38 crore back to the MA account from the current account before the end of the quarter (on June 29 and 30, 2026), which are parked as unutilized issue proceeds on June 30, 2026. Whether all utilization is as per the disclosures in the CA certificate*, Placement document, However, same is contrary to the ‘interim use of net proceeds’ as Offer Document? management declaration defined in offer document. The offer document specifies the timeline for implementation of net proceeds of Rs. 75.29 crore as March 31, 2026. However, total net QIP proceeds of Rs. 75.16 crore remains unutilized as on June 30, 2026, including Rs. 46.92 crore which were intended to be utilized till March 31, 2026. As per the offer document, the implementation of objects could be rescheduled or revised at the discretion of the management, subject to compliance with Source of information / certifications Comments of the Particulars Reply considered by Monitoring Agency for Comments of the Monitoring Agency Board of Directors preparation of report applicable laws. The MA has received an email from the company’s compliance officer defining the management as Mr. Sajid Malik (Chairman & MD) and Mr. Ravi Kumar Jatavallabha V (Chief Financial Officer), jo [Showing first 8,000 characters — download PDF for full document]